Loading...
Loading...
- OvaScience Inc OVAS shares tumbled 50.4 percent to $1.47 after the company announced plans to reduce workforce by 30 percent and disclosed that its CEO Harald Stock is stepping down.
- Aurinia Pharmaceuticals Inc AUPH shares dipped 21.8 percent to $2.13 after the company reported a US$25.0 million bought deal financing.
- Lpath Inc LPTN shares fell 16.4 percent to $3.05. Lpath shares have increased 11.61 percent over the past 52 weeks, while the S&P 500 index has gained 11.09 percent in the same period.
- Red Hat Inc RHT shares dropped 12.2 percent to $70.07. Red Hat reported upbeat earnings for its third quarter, but sales missed expectations. The company also announced that its CFO Frank Calderoni is stepping down.
- AAR Corp. AIR shares declined 8.8 percent to $34.27. AAR reported Q2 earnings from continuing operations of $0.35 per share on revenue of $423.8 million.
- Zumiez Inc. ZUMZ fell 8.6 percent to $20.85. B. Riley downgraded Zumiez from Buy to Neutral and lowered the price target from $27.00 to $25.00.
- Kirkland's, Inc. KIRK dropped 8.1 percent to $15.29. B. Riley downgraded Kirkland's from Buy to Neutral.
- GEE Group Inc JOB shares slipped 8 percent to $4.10 after the company reported consolidated financial results for the fourth quarter and fiscal year. GEE Group posted net income of around $1 million on revenue of $21.8 million.
- Delcath Systems, Inc. DCTH shares fell 8 percent to $1.04. Delcath shares have tumbled 87.61 percent over the past 52 weeks, while the S&P 500 index has gained 11.09 percent in the same period.
- Bed Bath & Beyond Inc. BBBY declined 6.4 percent to $42.63 after the company reported weaker-than-expected results for its third quarter on Wednesday.
- Fred's, Inc. FRED dropped 5.6 percent to $19.21. Fred's shares have climbed 25.23 percent over the past 52 weeks, while the S&P 500 index has gained 11.09 percent in the same period.
- Finish Line Inc FINL shares fell 3.8 percent to $20.21. Bank of America downgraded Finish Line from Buy to Neutral, while Canaccord Genuity downgraded the stock from Buy to Hold.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
